Citation: Rt. Reid et al., Does apolipoprotein E (Apo-E) genotype influence nicotinic receptor binding in Alzheimer's disease, J NEURAL TR, 108(8-9), 2001, pp. 1043-1050
Authors:
Sabbagh, MN
Reid, RT
Hansen, LA
Alford, M
Thal, LJ
Citation: Mn. Sabbagh et al., Correlation of nicotinic receptor binding with clinical and neuropathological changes in Alzheimer's disease and dementia with Lewy bodies, J NEURAL TR, 108(10), 2001, pp. 1149-1157
Citation: Rt. Reid et al., Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease, NEUROBIOL A, 21(5), 2000, pp. 741-746
Authors:
Chavez-Noriega, LE
Gillespie, A
Stauderman, KA
Crona, JH
Claeps, BO
Elliott, KJ
Reid, RT
Rao, TS
Velicelebi, G
Harpold, MM
Johnson, EC
Corey-Naeve, J
Citation: Le. Chavez-noriega et al., Characterization of the recombinant human neuronal nicotinic acetylcholinereceptors alpha 3 beta 2 and alpha 4 beta 2 stably expressed in HEK293 cells, NEUROPHARM, 39(13), 2000, pp. 2543-2560
Citation: Rt. Reid et al., Pharmacological characterization of nicotine-induced acetylcholine releasein the rat hippocampus in vivo: evidence for a permissive dopamine synapse, BR J PHARM, 127(6), 1999, pp. 1486-1494